Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for lyrica
Event Report: UCL IBIL - Pregabalin: Where stand plausibility and Swiss-form claims? PART 1 Event Report: UCL IBIL - Pregabalin: Where stand plausibility and Swiss-form claims? PART 1 Reviewed by Dr Rose Hughes on Wednesday, January 09, 2019 Rating: 5
No pain, no gain: Plausibility in Warner-Lambert v Actavis No pain, no gain: Plausibility in Warner-Lambert v Actavis Reviewed by Dr Rose Hughes on Monday, November 26, 2018 Rating: 5
BREAKING NEWS: Supreme Court unanimously dismisses Warner-Lambert's painful Lyrica appeal BREAKING NEWS: Supreme Court unanimously dismisses Warner-Lambert's painful Lyrica appeal Reviewed by Dr Rose Hughes on Wednesday, November 14, 2018 Rating: 5
Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle Reviewed by Eleonora Rosati on Thursday, February 22, 2018 Rating: 5
AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement Reviewed by David Brophy on Thursday, December 08, 2016 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.